Stevens-Johnson syndrome induced by mizoribine in a patient with systemic lupus erythematosus

Modern Rheumatology

Volumn 16, Issue 2, 2006, Pages 113-116

  Matsushita, Kakushi ^a   Ozaki, Atsuo ^a   Inoue, Hirosaka ^a   Kaieda, Tomoe ^b   Akimoto, Masaki ^a   Satomura, Atsushi ^c   Arima, Naomichi ^a   Hamada, Heiichiro ^a   Suruga, Yukio ^a   Aoki, Noriko ^a   Fujiwara, Hiroshi ^a   Tei, Chuwa ^b  

^a KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Mizoribine; Stevens Johnson syndrome (SJS); Systemic lupus erythematosus (SLE)

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GANCICLOVIR; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MICAFUNGIN; MIZORIBINE; PREDNISOLONE;

ABDOMINAL PAIN; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLINDNESS; CASE REPORT; CLINICAL FEATURE; CONVULSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; LABORATORY TEST; LEUKOENCEPHALOPATHY; LUPUS ERYTHEMATOSUS NEPHRITIS; MYCOSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STEVENS JOHNSON SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CYCLOPHOSPHAMIDE; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LUPUS NEPHRITIS; PREDNISOLONE; RIBONUCLEOSIDES; STEVENS-JOHNSON SYNDROME; TREATMENT OUTCOME;

EID: 33645985135     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-006-0467-5     Document Type: Article

References (15)

1. M Pistiner DJ Wallace S Nessim AL Melzger JR Klineberg 1991 Lupus erythematosus in the 1980s: A survey of 570 patients Semin Arthritis Rheum 21 55-64 10.1016/0049-0172(91)90057-7 1:STN:280:By2D2MvmtlU%3D 1948102
2. GG Illei HA Austin M Crone L Collins MF Gourley CH Yorboro et al. 2001 Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis Ann Intern Med 135 248-57 1:CAS:528:DC%2BD3MXms1WjtLc%3D 11511139
3. K Yoshioka K Ohashi T Sakai H Ito N Yoshikawa H Nakamura et al. 2000 A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome Kidney Int 58 317-24 10.1046/ j.1523-1755.2000.00168.x 1:CAS:528:DC%2BD3cXltVyjtbY%3D 10886577
4. D Cacccavo B Lagana AP Mitterhofer GM Ferri A Afeltra A Amoroso et al. 1997 Long-term treatment of systemic lupus erythematosus with cyclosporine A Arthritis Rheum 40 27-35
5. EJ Kingdon AG Mclean E Psimenou A Davenport SH Powis P Sweny et al. 2001 The safety and efficacy of MMF in lupus nephritis: A pilot study Lupus 10 606-11 10.1191/096120301682430186 1:CAS:528:DC%2BD3MXotFyjtLs%3D 11678448
6. BS Mitchell JS Dayton LA Turka CB Thompson 1993 IMP dehydrogenase inhibitors as immunomodulators Ann N Y Acad Sci 685 217-24 1:CAS:528:DyaK3sXlsleku7Y%3D 8103312
7. Y Aihara T Miyamae S Ito S Kobayashi T Imagawa M Mori et al. 2002 Mizoribine as an effective combined maintenance therapy with prednisolone in child-onset systemic lupus erythematosus Pediatr Int 44 199-204 10.1046/j.1328-8067.2001.01534.x 1:CAS:528:DC%2BD38XjtlCisb0%3D 11896887
8. K Yoshidome S Takei H Imanaka N Maeno T Ohkawa Y Kawano 2004 Efficacy of mizoribine in the treatment of systemic lupus erythematosus in children Pediatr Int 46 444-9 10.1111/j.1442-200x.2004.01923.x 1:CAS:528:DC%2BD2cXnslyiu7g%3D 15310311
9. H Tanaka T Abe S Nishimura H Sakai H Kimura M Oki et al. 2004 A case of rheumatoid arthritis/Sjogren's syndrome with acute renal failure due to hyperuricemia associated with mizoribine therapy Jpn J Clin Immunol 27 171-6
10. T Shibasaki A Koyama A Hishida E Muso G Osawa H Yamabe et al. 2004 A randomized open-label comparative study of conventional therapy versus mizoribine only therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey) Clin Exp Nephrol 8 117-26 10.1007/ s10157-004-0276-0 1:CAS:528:DC%2BD2cXlvFSgur0%3D 15235928
11. S Bstuji-Garin N Fouchard M Bertocchi JC Roujeau J Revuz P Walkenstein 2000 SCORTEN: A severity-of-illness score for toxic epidermal necrolysis J Invest Dermatol 115 149-53
12. C Prins C Vittorio RS Padilla T Hunziker P Itin J Forster et al. 2003 Effect of high-dose intravenous immunoglobulin therapy in Stevens-Johnson syndrome: A retrospective, multicenter study Dermatology 207 96-9 10.1159/000070957 1:CAS:528:DC%2BD3sXltlChtLk%3D 12835566
13. H Mori K Yamanaka M Kaketa K Tamada A Hakamada K Isoda et al. 2004 Drug eruption caused by azathioprine: Value of using the drug-induced lymphocytes stimulation test for diagnosis J Dermatol 31 731-6 1:CAS:528:DC%2BD2cXhtVOms7bK 15628319
14. R Wolf H Matz B Macros E Orion 2005 Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrosis: The dilemma of classification Clin Dermatol 23 311-4 15896547
15. J Hinchey C Chaves B Appignani J Breen L Pao A Wang et al. 1996 A reversible posterior leukoencephalopathy syndrome N Engl J Med 334 494-500 10.1056/NEJM199602223340803 1:STN:280:BymC2MjgtFc%3D 8559202